RNS Number: 4972 D Frontier IP Group plc 19 February 2020 TR-1: S tandard form for notification of major holdings. This information is provided by RNS, the news service of the London Stock Exchange. RNS is approved by the Financial Conduct Authority to act as a Primary Information Provider in the United Kingdom.
Frontier IP Group Plc #FIPP announced that Cambridge Raman Imaging Limited, in which the company owns 33.3% stake, has been awarded €140,000 by the European Union's Graphene Flagship to accelerate development of its innovative graphene-enabled scanning Raman microscope. The Cambridge Raman Imaging is initially developing a raman-imaging scanning microscope to diagnose and track tumors, and for other detection applications.
RNS Number: 1331 D Frontier IP Group plc 17 February 2020 RNS REACH. Portfolio news- Cambridge Raman Imaging wins€ 140,000 EU Graphene Flagship funding. The Company, a spin out from the University of Cambridge and the Politecnico di Milano in Italy, was incorporated in March 2018 to develop and commercialise the joint work of both universities to create...
Frontier IP Group (FIPP.L) 65p £32.9m Frontier IP, a specialist in commercialising intellectual property, has raised its equity stake in portfolio company Celerum Limited from 10 per cent to 33.8 per cent. The increase is in return for an investment of £25,000, converting a previous loan of £21,818 into equity, and for providing £50,000 worth of additional strategic, business and hands-on software development services. Celerum, a spin out from Robert Gordon University ("RGU"), Aberdeen, is developing novel artificial intelligence to help businesses improve the operational efficiency of logistics and supply chains. It also has the potential to tackle a host of other complex scientific, engineering and industrial challenges. Frontier IP is stepping up its support for the Company in response to increased industry interest. #FIPP
RNS Number: 6770 C Frontier IP Group plc 12 February 2020 RNS Reach. Portfolio news- Frontier IP raises stake in real-time, nature-inspired Artificial Intelligence company Celerum to 33.8 per cent. The increase is in return for an investment of £25,000, converting a previous loan of £21,818 into equity, and for providing £50,000 worth of additional...
RNS Number: 4952 B Frontier IP Group plc 31 January 2020 RNS Reach. A phase I clinical study of the drug candidate DSP-1181, designed to treat obsessive-compulsive disorder as an initial indication, has started in Japan.. Sumitomo Dainippon Pharma Co., Ltd. and Exscientia Ltd. announce that a phase I clinical study of DSP-1181, that was created using Artificial...
Portfolio news- The Vaccine Group raises £680,000 to accelerate development of novel vaccine technology. Frontier IP, a specialist in commercialising university intellectual property, today announces that portfolio company The Vaccine Group Limited has raised £680,000 through its first equity funding round.. The fundraising values the University of...
RNS Number: 0758 A Frontier IP Group plc 16 January 2020 TR-1: S tandard form for notification of major holdings. This information is provided by RNS, the news service of the London Stock Exchange. RNS is approved by the Financial Conduct Authority to act as a Primary Information Provider in the United Kingdom.
A prototype raspberry picking robot successfully completed two field trials last year in collaboration with Hall Hunter Partnership, one of the UK's leading soft fruit growers.. As part of the fundraising, Frontier IP converted a loan of £48,000 into equity, with £250,000 being raised from new investors. The funding round values the University of Plymouth...
RNS Number: 3680 Z Frontier IP Group plc 10 January 2020 RNS Reach. Portfolio news- Exscientia enters collaboration with Bayer AG to leverage the potential of Artificial Intelligence in cardiovascular and oncology drug discovery. Under the terms of the agreement, Exscientia may be eligible to receive up to €240 million including upfront and research...
RNS Number: 3125 Y Frontier IP Group plc 31 December 2019 31 December 2019. Frontier IP, which specialises in commercialising university intellectual property, announces that the Company's issued share capital as at the date of this announcement comprises 50,681,372 ordinary shares of 10 pence each, with one voting right per share. The Company does not hold...
Frontier IP, a specialist in commercialising university intellectual property, announces that the Board of Directors approved the issue and allotment of 250,000 Ordinary Shares of 10 pence each in the Group subject to and conditional upon admission to trading on AIM. The exercise price was 26.63 pence. Following the anticipated admission of these shares,...
RNS Number: 5864 W Frontier IP Group plc 11 December 2019 TR-1: S tandard form for notification of major holdings. This information is provided by RNS, the news service of the London Stock Exchange. RNS is approved by the Financial Conduct Authority to act as a Primary Information Provider in the United Kingdom.
RNS Number: 2542 W Frontier IP Group plc 09 December 2019 TR-1: S tandard form for notification of major holdings. This information is provided by RNS, the news service of the London Stock Exchange. RNS is approved by the Financial Conduct Authority to act as a Primary Information Provider in the United Kingdom.
RNS Number: 2541 W Frontier IP Group plc 09 December 2019 TR-1: S tandard form for notification of major holdings. This information is provided by RNS, the news service of the London Stock Exchange. RNS is approved by the Financial Conduct Authority to act as a Primary Information Provider in the United Kingdom.
RNS Number: 2451 W Frontier IP Group plc 09 December 2019 TR-1: S tandard form for notification of major holdings. This information is provided by RNS, the news service of the London Stock Exchange. RNS is approved by the Financial Conduct Authority to act as a Primary Information Provider in the United Kingdom.
RNS Number: 1879 W Frontier IP Group plc 09 December 2019 TR-1: S tandard form for notification of major holdings. This information is provided by RNS, the news service of the London Stock Exchange. RNS is approved by the Financial Conduct Authority to act as a Primary Information Provider in the United Kingdom.
RNS Number: 1228 W Frontier IP Group plc 09 December 2019 9 December 2019. Frontier IP Group plc, a specialist in commercialising university intellectual property, announces that, on 6 December 2019, the Board granted options over ordinary shares of 10 pence each in the Company to certain Executive Directors and personnel of the Company.. Certain of the Options...
RNS Number: 1171 W Frontier IP Group plc 06 December 2019 TR-1: S tandard form for notification of major holdings. This information is provided by RNS, the news service of the London Stock Exchange. RNS is approved by the Financial Conduct Authority to act as a Primary Information Provider in the United Kingdom.
RNS Number: 8521 V Frontier IP Group plc 05 December 2019 TR-1: S tandard form for notification of major holdings. This information is provided by RNS, the news service of the London Stock Exchange. RNS is approved by the Financial Conduct Authority to act as a Primary Information Provider in the United Kingdom.
Bid
-
-
-
Ask
  • High
    -
  • OPEN
    -
  • VOL
    -
  • MKT CAP
    -m
  • LOW
    -
  • CLOSE
    -
  • AVG VOL
    -
  • SHARES IN ISSUE
    42.11M
Watchlist